Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

OBJECTIVE: There are no direct comparisons between escitalopram and paroxetine controlled release in patients with major depressive disorder (MDD). METHODS: We conducted a 24-week, rater-masked, randomized trial of escitalopram (5–20 mg/day) versus paroxetine controlled release (12.5–50 mg/day) in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Taro, Matsuda, Yuki, Matsunaga, Shinji, Moriwaki, Masatsugu, Otake, Yoichiro, Akamatsu, Kaku, Okochi, Tomo, Hirano, Shigeki, Funahashi, Toshihiko, Okuda, Momoko, Tabuse, Hideaki, Fujita, Kiyoshi, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230634/
https://www.ncbi.nlm.nih.gov/pubmed/28123299
http://dx.doi.org/10.2147/NDT.S124898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230634/
https://www.ncbi.nlm.nih.gov/pubmed/28123299
http://dx.doi.org/10.2147/NDT.S124898

Ejemplares similares